Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy RFV Medrano, A Hunger, SA Mendonça, JAM Barbuto, BE Strauss Oncotarget 8 (41), 71249, 2017 | 177 | 2017 |
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death A Hunger, RFV Medrano, DB Zanatta, PR Del Valle, CA Merkel, TA Salles, ... Cell Death Discovery 3 (1), 1-12, 2017 | 32 | 2017 |
Timp1 promotes cell survival by activating the PDK1 signaling pathway in melanoma M Toricelli, FHM Melo, A Hunger, D Zanatta, BE Strauss, MG Jasiulionis Cancers 9 (4), 37, 2017 | 29 | 2017 |
Intratumoral immunization by p19Arf and interferon-β gene transfer in a heterotopic mouse model of lung carcinoma JPP Catani, RFV Medrano, A Hunger, P Del Valle, S Adjemian, ... Translational Oncology 9 (6), 565-574, 2016 | 26 | 2016 |
Vaccination using melanoma cells treated with p19arf and interferon beta gene transfer in a mouse model: a novel combination for cancer immunotherapy RFV Medrano, JPP Catani, AH Ribeiro, SL Tomaz, CA Merkel, ... Cancer Immunology, Immunotherapy 65, 371-382, 2016 | 26 | 2016 |
Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector RE Tamura, A Hunger, DC Fernandes, FR Laurindo, E Costanzi-Strauss, ... Human gene therapy 28 (8), 639-653, 2017 | 23 | 2017 |
Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death RFV Medrano, A Hunger, JPP Catani, BE Strauss Oncoimmunology 6 (7), e1329072, 2017 | 12 | 2017 |
Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy A Hunger, RFV Medrano, BE Strauss Cell Death & Disease 8 (5), e2784, 2017 | 12 | 2017 |
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget. 2017; 8 (41): 71249–84 RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss | 7 | |
miR-138-5p induces aggressive traits by targeting Trp53 expression in murine melanoma cells, and correlates with poor prognosis of melanoma patients AT da Cruz, A Hunger, FHM de Melo, AC Monteiro, GC Pare, D Lai, ... Neoplasia 23 (8), 823-834, 2021 | 6 | 2021 |
Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. Oncotarget 8, 71249–71284 RFV Medrano, A Hunger, SA Mendonca, JAM Barbuto, BE Strauss | 6 | 2017 |
Exploration of p53 plus interferon-beta gene transfer for the sensitization of human colorectal cancer cell lines to cell death PR Del Valle, SA Mendonça, F Antunes, A Hunger, RE Tamura, ... Cancer Biology & Therapy 22 (4), 301-310, 2021 | 5 | 2021 |
Response of human melanoma cell lines to interferon-beta gene transfer mediated by a modified adenoviral vector TIP David, OLD Cerqueira, MG Lana, RFV Medrano, A Hunger, ... Scientific Reports 10 (1), 17893, 2020 | 5 | 2020 |
Induction of Immune-Stimulating Factors and Oncolysis Upon p14ARF Gene Transfer in Melanoma Cell Lines SA Mendonça, F Antunes, OLD Cerqueira, PR Del Valle, A Hunger, ... DNA and Cell Biology 42 (6), 274-288, 2023 | 2 | 2023 |
Potentiation of combined p19Arf and interferon-beta cancer gene therapy through its association with doxorubicin chemotherapy RFV Medrano, TA Salles, R Dariolli, F Antunes, VA Feitosa, A Hunger, ... Scientific Reports 12 (1), 13636, 2022 | 2 | 2022 |
Distinct Roles of Direct Transduction Versus Exposure to the Tumor Secretome on Murine Endothelial Cells After Melanoma Gene Therapy with Interferon-β and p19Arf IL Vieira, RE Tamura, A Hunger, BE Strauss Journal of Interferon & Cytokine Research 39 (4), 246-258, 2019 | 2 | 2019 |
p19Arf sensitizes B16 melanoma cells to interferon-β delivered via mesenchymal stem cells in vitro RC Da-Costa, IL Vieira, A Hunger, RE Tamura, BE Strauss Brazilian Journal of Medical and Biological Research 53, e8876, 2020 | 1 | 2020 |
Abstract B134: Use of p19Arf/interferon-β immunotherapy in association with chemotherapy permits reduced drug dosage and avoids cardiotoxicity associated with doxorubicin BE Strauss, RFV Medrano, R Tamura, SA Mendonça, VA Feitosa, ... Cancer Immunology Research 7 (2_Supplement), B134-B134, 2019 | | 2019 |
Circadian phase, chronotype and sleep-wake cycle under real-life conditions: the baependi heart study cohort FS Ruiz, F Beijamini, B Gonçalves, B Middleton, JE Krieger, H Vallada, ... Sleep Medicine, 2019 | | 2019 |
Use of p19Arf/interferon-beta immunotherapy in association with chemotherapy permits reduced drug dosage and avoids cardiotoxicity associated with doxorubicin BE Strauss, RFV Medrano, R Tamura, SA Mendonca, VA Feitosa, ... Cancer Immunology Research, 2019 | | 2019 |